Erratum: The role of CD95 and CD95 ligand in cancer

descriptionPublicationkeyboard_double_arrow_right Article 07 Apr 2015 English Publisher:Springer Science and Business Media LLCJournal:Cell Death & Differentiation, volume 22, pages 885-886 (issn: 1350-9047, eissn: 1476-5403,

Copyright policy )

Authors: M E Peter; A Hadji; A E Murmann; S Brockway; W Putzbach; A Pattanayak; P Ceppi;

doi: 10.1038/cdd.2015.25

Erratum: The role of CD95 and CD95 ligand in cancer

- Summary
- Metrics

Abstract

Correction to: Cell Death and Differentiation (2015) 22, 549–559; doi:10.1038/cdd.2015.3; published online 6 February 2015 Since the publication of this article the authors have noted that they have inadvertently failed to list an important paper in the field in Table 2. This work (Kleber et al.) has now been added to the revised Table 2 shown below.

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	69
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%